News from the FDA/CDC

News from the FDA/CDC

FDA approves first tocilizumab biosimilar

Tocilizumab-bavi (Tofidence) will offer a lower-cost option for patients with autoimmune conditions, the drug manufacturer, Biogen, stated.

News from the FDA/CDC

FDA panel deems phenylephrine ineffective

The committee’s next move is to determine if the drug’s status as Generally Recognized as Safe and Effective should be revoked.

Pages